Thermo Fisher Scientific Inc.

New Capabilities

Major competitor after acquiring Olink

Alamar Biosciences raised $191 million in its initial public offering on April 17, 2026 — nearly double the $100 million it originally planned — after investor demand exceeded available shares by more than tenfold. Shares priced at $17, opened at $22.60, and closed at $22.00, a 29% first-day gain that gave the company a market capitalization of roughly $1.53 billion. The Fremont, California company develops technology that detects proteins in blood at concentrations so low that conventional tests miss them entirely, potentially catching diseases years earlier than current methods allow. CEO and founder Yuling Luo told Reuters the company plans to use the proceeds to expand into cancer, cardiology, and other major disease areas. The company reported $74.2 million in revenue for fiscal year 2025 — nearly triple the prior year — giving public investors a baseline for measuring commercial growth against the IPO's lofty expectations.

Updated Apr 18

Money Moves

Acquirer; integrating Clario into its Laboratory Products and Biopharma Services segment

Thermo Fisher Scientific, one of the world's largest scientific instrumentation companies, closed its $8.875 billion cash purchase of Clario Holdings on March 24, 2026. Clario provides the digital tools that pharmaceutical companies use to collect patient data during clinical trials — technology that has contributed to roughly 70 percent of drugs approved by the Food and Drug Administration (FDA) over the past decade. The deal, first announced in October 2025, also includes up to $525 million in additional payments tied to Clario's near-term performance, bringing the total potential price to approximately $9.4 billion.

Updated Mar 24

Money Moves

Acquired Solventum's Purification & Filtration business for $4.1 billion

Over the past 12 months, four major deals totaling over $15 billion have transformed the industrial filtration industry. Parker Hannifin agreed to pay $9.25 billion for Filtration Group in November 2025 (pending regulatory approval). Thermo Fisher acquired Solventum's filtration unit for $4.1 billion in February 2025. Atmus Filtration closed its $450 million purchase of Koch Filter on January 7, 2026. Most recently, on February 2, 2026, Filtration Group agreed to sell its Facet aviation fuel filtration business to Donaldson Company for $820 million.

Updated Feb 5